Overview

Evaluation of Gastrointestinal Transit Pre and Pos Treatment With Non Selective Betablocker in a Population of Cirrhotics

Status:
Unknown status

Trial end date:
2021-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the influence of non betablockers in gastrointestinal motility (transit time) in patients with liver cirrhosis.

Phase:

N/A

Details

Lead Sponsor:

ALDO TORRE DELGADILLO

Treatments:

Adrenergic beta-Antagonists
Propranolol